Blueprint Medicines Corporation
BPMC
$87.38
-$2.64-2.93%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 615.49M | 734.17M | 763.60M | 647.90M | 710.64M |
Total Receivables | 77.61M | 65.81M | 85.06M | 60.05M | 43.18M |
Inventory | 13.61M | 12.53M | 14.79M | 30.94M | 21.22M |
Prepaid Expenses | 35.97M | 42.33M | 39.91M | 37.71M | 33.35M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | 183.00K | -- | -- |
Total Current Assets | 742.68M | 854.85M | 903.54M | 776.60M | 808.39M |
|
|||||
Total Current Assets | 742.68M | 854.85M | 903.54M | 776.60M | 808.39M |
Net Property, Plant & Equipment | 100.77M | 104.27M | 109.05M | 113.17M | 115.65M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 59.21M | 63.66M | 58.31M | 33.21M | 40.89M |
Total Assets | 1.18B | 1.20B | 1.20B | 1.04B | 1.05B |
|
|||||
Total Accounts Payable | 6.79M | 4.72M | 4.86M | 4.93M | 4.71M |
Total Accrued Expenses | 102.27M | 99.71M | 96.26M | 86.51M | 110.53M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 118.91M | 117.95M | 114.66M | 87.15M | 81.41M |
Total Finance Division Other Current Liabilities | 32.82M | 35.29M | 28.02M | 28.01M | 18.28M |
Total Other Current Liabilities | 32.82M | 35.29M | 28.02M | 28.01M | 18.28M |
Total Current Liabilities | 260.80M | 257.66M | 243.80M | 206.60M | 214.92M |
|
|||||
Total Current Liabilities | 260.80M | 257.66M | 243.80M | 206.60M | 214.92M |
Long-Term Debt | 536.58M | 542.84M | 550.45M | 432.30M | 610.96M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 68.79M | 71.92M | 75.24M | 78.49M | 81.75M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 14.99M | 14.08M | 13.83M | 10.40M | 11.01M |
Total Liabilities | 881.15M | 886.50M | 883.32M | 727.79M | 918.64M |
|
|||||
Common Stock & APIC | 2.71B | 2.67B | 2.62B | 2.57B | 2.47B |
Retained Earnings | -2.41B | -2.36B | -2.30B | -2.25B | -2.34B |
Treasury Stock & Other | -3.55M | -1.07M | -3.89M | -3.85M | -3.50M |
Total Common Equity | 298.67M | 313.15M | 320.24M | 310.69M | 130.61M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 298.67M | 313.15M | 320.24M | 310.69M | 130.61M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 298.67M | 313.15M | 320.24M | 310.69M | 130.61M |
|